Current status and prospects of antiplatelet therapy in percutaneous coronary intervention in Japan: Focus on adenosine diphosphate receptor inhibitors

被引：11
|
作者：
Ogawa, Hisao [1 ]
Hokimoto, Seiji [1 ]
Kaikita, Koichi [1 ]
Yamamoto, Koichiro [1 ]
Chitose, Tadasuke [1 ]
Ono, Takamichi [1 ]
Tsujita, Kenichi [1 ]
机构：
[1] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan
来源：
JOURNAL OF CARDIOLOGY | 2011年 / 58卷 / 01期
关键词：
Cardiovascular disease; Platelet inhibitors; Thrombosis; Drug therapy; Adenosine diphosphate; ELEVATION MYOCARDIAL-INFARCTION; ASPIRIN-TREATED PATIENTS; PROTON PUMP INHIBITORS; INDUCED HEPATOTOXICITY; STENT IMPLANTATION; DIABETES-MELLITUS; AMERICAN-COLLEGE; HEALTHY CHINESE; ARTERY-DISEASE; DOUBLE-BLIND;
D O I：
10.1016/j.jjcc.2011.03.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Dual antiplatelet therapy with aspirin and clopidogrel is routinely used to prevent thrombotic events in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) in Japan. However, these agents have various limitations and some patients will experience further cardiovascular events. The purpose of this article is to review the antiplatelet agents currently used in patients undergoing PCI in Japan, to discuss the issues and limitations associated with these antiplatelet agents, and to characterize new antiplatelet agents currently under investigation in Japan. Particular emphasis is placed on the novel thienopyridine prasugrel, and the potential this drug has for overcoming the issues associated with other antiplatelet agents. (C) 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：6 / 17
页数：12
相关论文
共 50 条
  • [31] Oral antiplatelet therapy in the elderly undergoing percutaneous coronary intervention: an umbrella review
    Biondi-Zoccai, Giuseppe
    Antonazzo, Barbara
    Giordano, Arturo
    Versaci, Francesco
    Frati, Giacomo
    Ronzoni, Stefano
    Nudi, Alessandro
    Nudi, Francesco
    JOURNAL OF THORACIC DISEASE, 2020, 12 (04) : 1656 - 1664
  • [32] Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Gott, Koji
    Nakai, Kentaro
    Shizuta, Satoshi
    Morimoto, Takeshi
    Shiomi, Hiroki
    Natsuaki, Masahiro
    Yahata, Mitsuhiko
    Ota, Chihiro
    Ono, Koh
    Makiyama, Takeru
    Nakagawa, Yoshihisa
    Furukawa, Yutaka
    Kadota, Kazushige
    Takatsu, Yoshiki
    Tamura, Takashi
    Takizawa, Akinori
    Inada, Tsukasa
    Doi, Osamu
    Nohara, Ryuji
    Matsuda, Mitsuo
    Takeda, Teruki
    Kato, Masayuki
    Shirotani, Manabu
    Eizawa, Hiroshi
    Ishii, Katsuhisa
    Lee, Jong-Dae
    Takahashi, Masaaki
    Horie, Minoru
    Takahashi, Mamoru
    Miki, Shinji
    Aoyama, Takeshi
    Suwa, Satoru
    Hamasaki, Shuichi
    Ogawa, Hisao
    Mitsudo, Kazuaki
    Nobuyoshi, Masakiyo
    Kita, Toru
    Kimura, Takeshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (01) : 70 - 78
  • [33] Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons
    Bonaventura, Klaus
    Sonntag, Steffen
    Kleber, Franz X.
    EUROINTERVENTION, 2011, 7 : K106 - K111
  • [34] Gender Differences in Cardiovascular Therapy: Focus on Antithrombotic Therapy and Percutaneous Coronary Intervention
    Gutierrez-Chico, Juan Luis
    Mehilli, Julinda
    DRUGS, 2013, 73 (17) : 1921 - 1933
  • [35] Intra-coronary physiology in contemporary percutaneous coronary intervention and anginal therapy with a focus on microvascular disease
    Alisiddiq, Zaheer
    Sharma, Harish
    Cotton, James
    Fan, Lampson
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [36] Optimal management of antiplatelet therapy and proton pump inhibition following percutaneous coronary intervention
    Mark R. Thomas
    Robert F. Storey
    Current Treatment Options in Cardiovascular Medicine, 2012, 14 (1) : 24 - 38
  • [37] Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized controlled trials
    Galli, Mattia
    Angiolillo, Dominick J.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (04) : 390 - 396
  • [38] Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies
    Cavallari, Larisa H.
    Lee, Craig R.
    Franchi, Francesco
    Keeley, Ellen C.
    Rossi, Joseph S.
    Thomas, Cameron D.
    Gong, Yan
    McDonough, Caitrin W.
    Starostik, Petr
    Al Saeed, Maryam J.
    Been, Latonya
    Kulick, Natasha
    Malave, Jean
    Mulrenin, Ian R.
    Nguyen, Anh B.
    Terrell, Joshua N.
    Tillotson, Grace
    Beitelshees, Amber L.
    Winterstein, Almut G.
    Stouffer, George A.
    Angiolillo, Dominick J.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (08):
  • [39] Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention JACC Review Topic of the Week
    Sullivan, Alexander E.
    Nanna, Michael G.
    Wang, Tracy Y.
    Bhatt, Deepak L.
    Angiolillo, Dominick J.
    Mehran, Roxana
    Banerjee, Subhash
    Cantrell, Sarah
    Jones, W. Schuyler
    Rymer, Jennifer A.
    Washam, Jeffrey B.
    Rao, Sunil V.
    Ohman, E. Magnus
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (15) : 1550 - 1563
  • [40] The individualized antiplatelet therapy following percutaneous coronary intervention: a case report and literature review
    Li, Jing-Xiu
    Song, Zhao-Yan
    Jin, En-Ze
    Yan, Shu-Jun
    Li, Yang
    Chen, Ye-Ping
    Liu, Shi-Hao
    Han, Bai-He
    Guo, Long-Zhe
    Yin, Shuo
    Li, Xin
    Xia, De-Jun
    Li, Xue-Qi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 8774 - 8782
12345